2020
Exports
$1.48kWorld Rnk 0 / 0
Flag Rnk 0 / 0
falsefalseN/A
2022
PRODUCT COMPLEXITY IN Special Pharmaceuticals
0.61Rnk 321 / 1025
2020
Imports
$542kWorld Rnk 173 / 220
Flag Rnk 196 / 963

About

Imports In 2022, Gibraltar imported $542k in Special Pharmaceuticals, becoming the 173rd largest importer of Special Pharmaceuticals in the world. At the same year, Special Pharmaceuticals was the 196th most imported product in Gibraltar. Gibraltar imports Special Pharmaceuticals primarily from: United States ($199k), United Kingdom ($157k), Spain ($146k), Belgium ($34.2k), and Germany ($4.47k).

The fastest growing import markets in Special Pharmaceuticals for Gibraltar between 2021 and 2022 were United States ($190k), Belgium ($7.1k), and Turkey ($359).

Latest Trends

Mar 2024

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Special Pharmaceuticals. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2020)$1.48k
IMPORTS (2022)$542k
NET TRADE (2022)-$542k

In 2022, Gibraltar imported $542k in Special Pharmaceuticals, mainly from United States ($199k), United Kingdom ($157k), Spain ($146k), Belgium ($34.2k), and Germany ($4.47k).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Gibraltar's main exporting competitors in Special Pharmaceuticals were:
In 2022, Gibraltar's main importing competitors in Special Pharmaceuticals were:

Explore Visualizations

Trade Value of Special Pharmaceuticals by Exporters

Have questions, comments, or concerns?
Send us an e-mail: [email protected]
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with